The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line
- 30 September 1994
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 85 (1) , 59-63
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- THE ANTIPROLIFERATIVE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 PROMOTE LYSOPHOSPHOLIPID-MEDIATED INHIBITION OF NA+, K+-ADENOSINE TRIPHOSPHATASE-ACTIVITY IN CANCER CELL-LINES IN-VITROInternational Journal of Oncology, 1994
- α-Tocopherol Prevents Cyclosporine A-Mediated Activation of Phospholipase A2 and Inhibition of Na+, K+-Adenosine Triphosphatase Activity in Cultured Hamster Renal Tubular CellsToxicology and Applied Pharmacology, 1994
- Multidrug resistance during cancer chemotherapy — biotechnological solutions to a clinical problemTrends in Biotechnology, 1993
- Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.Journal of Clinical Oncology, 1993
- Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitroBritish Journal of Cancer, 1992
- Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin ABiochemical Pharmacology, 1989
- Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cellsBritish Journal of Cancer, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycinBiochemical Pharmacology, 1982
- A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis ActivityNature, 1957